Abstract
REJECTION continues to be the single largest impediment to successful organ transplantation1. Antilymphocyte globulin, which contains antibodies that react with the leukocyte common antigen known as CD45 (refs 2–6), has proved to be one of the most effective agents for preventing rejection. We have shown earlier that a monoclonal antibody directed against the RB isoform of CD45 substantially inhibits the alloreactivity of human CD4+ lymphocytes in vitro7. Here we investigate whether CD45RB could be an appropriate target for preventing renal allograft rejection in mice. Mice treated with two injections of a monoclonal antibody (MB23G2) (ref. 8) raised against CD4SRB protein all survived and had normal renal function. Furthermore, this antibody reversed acute rejection when therapy was delayed until day 4, and the mice survived for their natural lifespan. The immunosuppression achieved may find application in the pre-vention and treatment of transplant rejection in man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Suthanthiran, M. & Strom, T. B. New Engl. J. Med. 331, 365–376 (1994).
Fabre, J. W. & Williams, A. F. Transplantation 23, 349–359 (1977).
Warr, G. W. & Marchalonis, J. J. Immunochemistry 13, 753–758 (1976).
Fabre, J. W., Sunderland, C. A. & Williams, A. G. Transplantation 30, 167–173 (1980).
Bonnefoy-Berard, N., Vincent, C. & Revillard, J. P. Transplantation 51, 669–673 (1991).
Rebellato, L. M., Gross, U., Verbanac, K. M. & Thomas, J. M. Transplantation 57, 685–694 (1994).
Lazarovits, A. I., Poppema, S., White, M. J. & Karsh, J. Transplantation 54, 724–729 (1992).
Birkeland, M. L., Johnson, P., Trowbridge, I. S. & Pure, E. Proc. natn. Acad. Sci. U.S.A. 86, 6734–6738 (1989).
Zhang, Z. et al. Microsurgery 16, 103–109 (1995).
Lazarovits, A. I. et al. J. Immun. 150, 5163–5174 (1993).
Gajewski, T. F., Qian, D., Fields, P. & Fitch, F. W. Proc. natn. Acad. Sci. U.S.A. 91, 38–42 (1994).
Quan, D. et al. Transplantation 58, 808–816 (1994).
Trowbridge, I. S. & Thomas, M. L. A. Rev. Immun. 12, 85–116 (1994).
Ibrahim, S., Dawson, D. V. & Sanfilippo, F. Transplantation 59, 724–728 (1995).
Lazarovits, A. I., Osman, N., LeFeuvre, C. E., Ley, S. C. & Crumpton, M. J. J. Immun. 153, 3956–3966 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lazarovits, A., Poppema, S., Zhang, Z. et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 380, 717–720 (1996). https://doi.org/10.1038/380717a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/380717a0
This article is cited by
-
Expression of viral CD45 ligand E3/49K on porcine cells reduces human anti-pig immune responses
Scientific Reports (2023)
-
Host Expression of the CD8 Treg/NK Cell Restriction Element Qa-1 is Dispensable for Transplant Tolerance
Scientific Reports (2017)
-
The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin
Immunologic Research (2015)
-
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
Molecular Therapy (2011)
-
The complementary roles of deletion and regulation in transplantation tolerance
Nature Reviews Immunology (2003)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
